Strength
30 mg/1
Manufacturer
HRA PHARMA AMERICA, INC.NDC
73302045601
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ULIPRISTAL ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA022474On Market Since
5/11/2020
Pharmacological Classes
Progesterone Agonist/Antagonist
Selective Progesterone Receptor Modulators
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.